Fig. 6From: Neuroprotective effects of the PPARβ/δ antagonist GSK0660 in in vitro and in vivo Parkinson’s disease models(A-B) DAPI, Mitotracker deep red, and the masks produced by ImageJ are reported. In the black box, the area is magnified to better appreciate the mitochondrial morphology. (C) Western blotting and relative densitometric analysis for fission and fusion pathways. *** p < 0.0005; ** p < 0.005 vs. control (CTR). +++p < 0.0005; ++p < 0.005; +p < 0.05 vs. 6-OHDA (n = 3)Back to article page